Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa
This study is currently recruiting participants.
Study NCT00610753   Information provided by Stanford University
First Received: January 25, 2008   Last Updated: March 3, 2009   History of Changes

January 25, 2008
March 3, 2009
July 2006
September 2010   (final data collection date for primary outcome measure)
Body Mass Index
Same as current
Complete list of historical versions of study NCT00610753 on ClinicalTrials.gov Archive Site
Eating Disorder Psychopathology
Same as current
 
Comparison of Two Types of Family Therapy in the Treatment of Adolescent Anorexia Nervosa
Family Therapy in the Treatment of Adolescent Anorexia Nervosa

This study will compare the effectiveness of two different family treatments for the treatment of adolescent anorexia nervosa.

The long-term objective of this study is to enhance the treatment and outcome of anorexia nervosa (AN). Research on the treatment of AN has lagged that of other conditions, even other eating disorders such as bulimia nervosa. The focus of this study is on adolescent AN. Successful early treatment is likely to reduce the prevalence of chronic AN with its high rates of morbidity and mortality and high health care costs. The most promising treatment for adolescent AN is a specific form of family therapy called behavioral family therapy (BFT). This treatment is focused on the disordered eating behavior that characterizes AN and enables parents to refeed their child. Although there have been several small scale studies of BFT there has been no controlled comparison with another form of family therapy. Therefore we propose to use systems family therapy (SFT) which has been developed to represent the type of family therapy practiced in the community.

One hundred and sixty adolescents of both genders aged 12-18 years meeting DSM-IV criteria for anorexia nervosa will be entered to the study. Recruitment is projected to extend for 2 years. Participants will be randomly allocated to one of the two types of family therapy. Family therapy will be given for 36-weeks. For the purpose of the present study, patients will be followed for 12-months after the end of family treatment. Hence, each family will participate for approximately 2-years, with a total participation time of some 40-hours. In a sub-study blood will be drawn from those volunteering for genetic analysis focusing on the subset of non-responders to treatments.

Phase III
Interventional
Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study
Anorexia Nervosa
Behavioral: Family therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
160
April 2011
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:Diagnosis of anorexia nervosa with Ideal Body Weight >75%

Exclusion Criteria:Current psychotic illness or mental retardation that would prohibit the use of psychotherapy Medically unstable for outpatient treatment

Both
12 Years to 18 Years
No
Contact: James D Lock, MD (650) 723-5473 jimlock@stanford.edu
United States,   Canada
 
NCT00610753
James D Lock, MD, Stanford University School of Medicine
SU-12132007-933, 5 U01 MH076290; SPO#33857
Stanford University
  • Katherine Halmi, MD
  • Craig Johnson, PhD
  • Harry Brandt, MD
  • Walter Kaye MD
  • Blake Woodside MD
  • Denise Wilfley, PhD
  • James D Lock, MD
Principal Investigator: Blake Woodside Toronto General Hospital
Principal Investigator: Denise Wilfley Washington University, Department of Psychiatry
Principal Investigator: Harry ABrandt Sheppard Pratt Health System
Sub-Investigator: James DLock Stanford University
Principal Investigator: Katherine Halmi Department of Psychiatry, Cornell University
Principal Investigator: Walter HKaye UCSD Center for Eating Disorder Treatment & Research
Stanford University
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP